☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
advisory committee
GSK's Belantamab Mafodotin Receives the US FDA Advisory Committee's Recommendation to Treat Relapsed/Refractory Multiple Myeloma
July 15, 2020
Merck Receives the US FDA Advisory Committee's Recommendation on Approval of Keytruda (pembrolizumab) for Patients with High-Risk...
December 18, 2019
AstraZeneca and Merck & Co Receive the US FDA Advisory Committee's Recommendation on Approval of Lynparza (olaparib) as 1L Mai...
December 18, 2019
Gilead Sciences Receives the US FDA Advisory Committee's Recommendation on Approval of Descovy for PrEP
August 8, 2019
Load more...
Back to Home
Modal title
×
Modal body text goes here.